Email ID
Password
Scrip   
Novavax shares slide on cash injection
25 November 2009
Christopher Spillane

Novavax's share price has tumbled by more than 15% in the days following the pricing of its public offering.

The vaccine developer raised net proceeds of around $21 million to fund preclinical and clinical trials of its virus-like-particle (VLP) technology as well as other research programmes...



Please Login to read the full article.
JOB OF THE WEEK Promote your vacancy here
© 2010 Informa plc. All rights reserved.
This site is owned and operated by Informa plc ("Informa") whose registered office is Mortimer House, 37-41 Mortimer Street, London, W1T 3JH. Registered in England and Wales. Number 3099067. UK VAT Group: GB 365 4626 36